SCHEMBL4469583

SCHEMBL4469583

O=C(c1cc(O)c(O)cc1Cl)N1CCOCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.71
MAPT P10636 1/20 0.71
HSP90AA1 P07900 2/20 0.69
KDM4E B2RXH2 2/20 0.69
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
CA3 P07451 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA5A P35218 1/20 0.65
CA7 P43166 1/20 0.65
CA9 Q16790 1/20 0.65
CA13 Q8N1Q1 1/20 0.65
CA14 Q9ULX7 1/20 0.65
CA5B Q9Y2D0 1/20 0.65
HTT P42858 2/20 0.62
CNR1 P21554 1/20 0.56
PKM P14618 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL487608 0.82 HSP90AA1 (1.00) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL1042677 0.82 KDM4E (1.00) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL9792231 0.82 KDM4E (0.77) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL16079573 0.81 KDM4E (0.75) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL487433 0.81 KDM4E (0.75) TSHRMAPTHSP90AA1KDM4EHTT
SCHEMBL2826036 0.80 MAPT (0.62) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL27738314 0.80 HTT (0.58) TSHRMAPTHSP90AA1KDM4EHTT
SCHEMBL4460921 0.80 MAPT (0.66) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL18424911 0.79 CA2 (1.00) TSHRMAPTHSP90AA1KDM4ECA12
SCHEMBL15651400 0.78 HSP90AA1 (0.76) TSHRMAPTHSP90AA1KDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 TSHR 1029/4885MAPT 4230/4885HSP90AA1 2340/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 TSHR 1171/4885MAPT 4527/4885HSP90AA1 1731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.